Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression: Results Through Week 144 of the SIMPL'HIV Trial.
Marinosci A, Sculier D, Wandeler G, Yerly S, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Decosterd L, Günthard HF, Schmid P, Limacher A, Branca M, Calmy A; Swiss HIV Cohort Study. Marinosci A, et al. Open Forum Infect Dis. 2024 Oct 16;11(11):ofae618. doi: 10.1093/ofid/ofae618. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39507885 Free PMC article. Clinical Trial.
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
Sculier D, Wandeler G, Yerly S, Marinosci A, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Buzzi M, Metzner KJ, Decosterd LA, Günthard HF, Schmid P, Limacher A, Egger M, Calmy A; Swiss HIV Cohort Study (SHCS). Sculier D, et al. Among authors: marinosci a. PLoS Med. 2020 Nov 10;17(11):e1003421. doi: 10.1371/journal.pmed.1003421. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33170863 Free PMC article. Clinical Trial.
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.
Courlet P, Barbieux C, Sculier D, Wandeler G, Stoeckle M, Bernasconi E, Braun D, Vernazza P, Cavassini M, Marinosci A, Smit M, Günthard HF, Schmid P, Limacher A, Guidi M, Alves Saldanha S, Decosterd LA, Calmy A. Courlet P, et al. Among authors: marinosci a. Br J Clin Pharmacol. 2021 Nov;87(11):4455-4460. doi: 10.1111/bcp.14832. Epub 2021 Apr 12. Br J Clin Pharmacol. 2021. PMID: 33764567 Free article. Clinical Trial.
Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.
Marinosci A, Sculier D, Wandeler G, Yerly S, Stoeckle M, Bernasconi E, Braun DL, Vernazza P, Cavassini M, Buzzi M, Metzner KJ, Decosterd L, Günthard HF, Schmid P, Limacher A, Branca M, Calmy A. Marinosci A, et al. Swiss Med Wkly. 2024 Apr 15;154:3762. doi: 10.57187/s.3762. Swiss Med Wkly. 2024. PMID: 38754068 Free article. Clinical Trial.
Prophylaxis for COVID-19: a systematic review.
Smit M, Marinosci A, Agoritsas T, Calmy A. Smit M, et al. Among authors: marinosci a. Clin Microbiol Infect. 2021 Apr;27(4):532-537. doi: 10.1016/j.cmi.2021.01.013. Epub 2021 Jan 18. Clin Microbiol Infect. 2021. PMID: 33476807 Free PMC article.
Possible link between anosmia and COVID-19: sniffing out the truth.
Marinosci A, Landis BN, Calmy A. Marinosci A, et al. Eur Arch Otorhinolaryngol. 2020 Jul;277(7):2149-2150. doi: 10.1007/s00405-020-05966-0. Epub 2020 Apr 17. Eur Arch Otorhinolaryngol. 2020. PMID: 32303881 Free PMC article. No abstract available.
Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial.
Smit M, Marinosci A, Nicoletti GJ, Perneger T, Ragozzino S, Andrey DO, Stoeckle M, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Back M, Schaubhut C, Fuchs S, Decosterd L, Battegay M, Guessous I, Chappuis F, Kaiser L, Labhardt ND, Calmy A. Smit M, et al. Among authors: marinosci a. BMJ Open. 2020 Nov 12;10(11):e040110. doi: 10.1136/bmjopen-2020-040110. BMJ Open. 2020. PMID: 33184083 Free PMC article.
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial.
Labhardt ND, Smit M, Petignat I, Perneger T, Marinosci A, Ustero P, Diniz Ribeiro MP, Ragozzino S, Nicoletti GJ, Faré PB, Andrey DO, Jacquerioz F, Lebowitz D, Agoritsas T, Meyer B, Spechbach H, Salamun J, Guessous I, Chappuis F, Kaiser L, Decosterd LA, Grinsztejn B, Bernasconi E, Cardoso SW, Calmy A, Team FTCS. Labhardt ND, et al. Among authors: marinosci a. EClinicalMedicine. 2021 Dec;42:101188. doi: 10.1016/j.eclinm.2021.101188. Epub 2021 Nov 6. EClinicalMedicine. 2021. PMID: 34778734 Free PMC article.
Routine Infectious Disease Consultation Prior to an Allogeneic Hematopoietic Cell Transplant.
Portillo V, Masouridi-Levrat S, Chalandon Y, Mappoura M, Morin S, Marinosci A, Giannotti F, Mamez AC, van Delden C, Neofytos D. Portillo V, et al. Among authors: marinosci a. Open Forum Infect Dis. 2023 Nov 16;10(12):ofad578. doi: 10.1093/ofid/ofad578. eCollection 2023 Dec. Open Forum Infect Dis. 2023. PMID: 38088980 Free PMC article.
72 results